 |
인쇄하기
취소
|
Myungmoon denies Teva’s takeover
Myungmoon Pharm Thursday dismissed the report of M&A (merger and acquisition) with Israel’s generic giant Teva Pharmaceutical Industries.
Ahn Do-gul, a ministry official of Health and Welfare, said Wednesday that Teva is negotiating with Korea’ mid-sized drug firm worth of 100 to 200 billion won to acquire majority of shares.
Teva is the largest generic drug manufacturer in the world and ...
Ahn Do-gul, a ministry official of Health and Welfare, said Wednesday that Teva is negotiating with Korea’ mid-sized drug firm worth of 100 to 200 billion won to acquire majority of shares.
Teva is the largest generic drug manufacturer in the world and ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.